Fort Lee, NJ, Nov. 02, 2026 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of complement-related conditions and oncology, today announced that it will host a conference call and webcast on Wednesday, November 4, 2026 at 8:00 AM ET to discuss recent business progress and financial results for the third quarter ended September 30, 2026. 

Conference Call and Webcast Information:
Date: 8:00 AM ET, Wednesday, November 4, 2026
Participant Dial-In (U.S.): 1-877-407-0752
Participant Dial-In (International): 1-201-389-0912
Conference ID: 13763643
Webcast Access: Please click here

The live and archived webcast can also be accessed by visiting the Nuvectis Pharma website on the Events and Presentations section of the Investor Relations page. A replay of the webcast will be archived for at least 30 days following the presentation.

About Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development of innovative therapies for the treatment of immune complement-related conditions and oncology. The Company’s pipeline includes ciprocopan (NXP100), a complement Factor B inhibitor in development for the treatment of complement-mediated diseases, and the oncology drug candidates NXP200 and NXP900, in development for the treatment of advanced cancers.

The company’s lead drug candidate is NXP100 (ciprocopan), a once-a-day Factor B inhibitor, with best-in-class potential, recently approved in China for the treatment of PNH patients previously untreated with complement inhibitors.

NXP200 is an oral, brain-penetrant, paradox-breaker BRAF inhibitor for the treatment of BRAF V600X-mutated and Class II/III non-V600-mutated solid tumor malignancies, with best-in-class potential.

NXP900 is an oral, small molecule inhibitor of the SRC family kinases, including SRC and YES1.

Company Contact:

Ron Bentsur
Chairman, Chief Executive Officer and President
rbentsur@nuvectis.com

Media Relations Contact:

Kevin Gardner
LifeSci Advisorskgardner@lifesciadvisors.com

Canberra Expands Its Smart Lighting Network Through the Upgrade of 16,000 Existing Streetlights Supporting Sustainability, Public Safety and Smart City Goals

  • City and Environment Directorate (CED) extends its collaboration with Omexom and Itron after seven years of smart lighting operations in Canberra.
  • Canberra plans to upgrade an additional 16,000 existing streetlights with Itron’s smart lighting technology, expanding the coverage of its smart lighting network.
  • The deployment supports enhanced public safety, improved operational efficiency and the ACT Government’s long-term sustainability and smart city objectives.

LIBERTY LAKE, Wash., Nov. 02, 2026 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), the intelligent infrastructure provider for modern energy and water management, is extending its long-standing collaboration with the ACT Government’s City and Environment Directorate (CED) and Itron channel partner Omexom to support the continued operation and future expansion of Canberra’s smart lighting infrastructure. Under the renewed arrangement, Canberra plans to expand its smart lighting network by upgrading an additional 16,000 existing streetlights with Itron’s External Networked Lighting Controller (NLC) technology while continuing to leverage Itron’s smart city platform to enhance public safety, reduce maintenance costs and improve operational efficiency.

Since 2019, CED, an ACT Government directorate responsible for planning, transport, city services and the environment in Canberra, has collaborated with Omexom and Itron to modernize Canberra’s street lighting infrastructure. At the time of deployment, the project was one of Australia’s largest standalone smart lighting programs. Today, the ACT Government owns and maintains more than 83,000 streetlights, with approximately 31,000 currently equipped with Itron NLC technology. Through the planned expansion of an additional 16,000 NLCs, smart lighting coverage will increase to more than 47,000 lights, representing nearly 60% of the ACT’s streetlighting network. Over the past seven years, CED has achieved measurable energy savings, enhanced operational visibility and maintained efficiency through Itron’s smart city solutions.

Today, CED uses Itron solutions to manage and optimize its street lighting network, including:

  • Real-time visibility and control of streetlighting operations through Itron’s CityEdge software platform
  • Remote monitoring and management of individual lighting assets using Itron’s NLC’s
  • Reliable connectivity for smart lighting infrastructure through Itron’s multi-transport, multi-application Network

The continued collaboration reinforces Canberra’s position as one of Australia’s leading smart lighting cities and provides a scalable foundation for future smart city applications. In addition to supporting lighting operations, the platform can accommodate future technologies such as environmental monitoring, traffic analytics and other connected city services.

CED has a number of sustainability initiatives focused on public transportation, including zero-emission bus and light rail programs. Through its ACT Transport Strategy, the organisation also promotes active travel options such as walking, cycling and micromobility devices to create a more sustainable, connected and accessible city.

Itron’s smart lighting platform supports these objectives by helping CED create safer and more connected public spaces. Through remote monitoring, adaptive lighting control and data-driven asset management, CED can help ensure pathways, streets and public areas are appropriately illuminated while improving operational efficiency and reducing energy consumption.

Omexom, a VINCI Energies brand and the primary delivery partner and contract holder with CED, will continue to integrate, deploy and operate the smart lighting solution. Itron provides the underlying technology platform, including its smart lighting controllers, Gen5 network, CityEdge software platform and future connected device ecosystem that enable remote monitoring, adaptive lighting control and data-driven asset management across Canberra’s streetlighting network.

Canberra is often ranked as a highly livable city when compared internationally, and 90% of Canberrans recommend the ACT as a good place to live, well above the national average of 77%. Maintaining smart, reliable infrastructure that supports safe public spaces is an important part of preserving that quality of life. Through our continued collaboration with Omexom and Itron, we are expanding Canberra’s smart lighting network to enhance services for the community while supporting our long-term sustainability and smart city objectives.

“For more than seven years, our collaboration with CED and Omexom has demonstrated how connected lighting infrastructure can help cities improve operational efficiency, support sustainability goals and create safer public spaces,” said John Marcolini, senior vice president of Networked Solutions at Itron. “As Canberra expands its smart lighting network, Itron’s platform will continue to provide a foundation for innovation, enabling future smart city applications and helping CED advance its long-term smart city vision.”

About Itron

Itron is transforming how the world manages energy, water and city services. Our trusted intelligent infrastructure solutions help utilities and cities improve efficiency, build resilience and deliver safe, reliable and affordable service. With edge intelligence, we connect people, data insights and devices so communities can better manage the essential resources they rely on to live and thrive. Join us as we create a more resourceful world: www.itron.com.

Itron® and the Itron Logo are registered trademarks of Itron, Inc in the United States and other countries and regions. All third-party trademarks are property of their respective owners and any usage herein does not suggest or imply any relationship between Itron and the third party unless expressly stated.

For additional information, contact:

Itron, Inc.

Alison Mallahan
Senior Manager, Corporate Communications
509-891-3802
PR@Itron.com

Paul Vincent
Vice President, Investor Relations
512-560-1172
Investors@itron.com

Itron, Inc.

SAN DIEGO, Nov. 02, 2026 (GLOBE NEWSWIRE) — Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment approach for ovarian cancer, today announced that on November 2, 2026, the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of 136,000 shares of the Company’s common stock to four (4) newly hired employees. The stock options were granted under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (2022 Inducement Plan) as an inducement material to each such individual’s entering into employment with Zentalis in accordance with Nasdaq Listing Rule 5635(c)(4).

The 2022 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Zentalis, or following a bona fide period of non-employment, as an inducement material to each such individual’s entering into employment with Zentalis, pursuant to Nasdaq Listing Rule 5635(c)(4).

The stock options have an exercise price of $1.85 per share, which is equal to the closing price of Zentalis’ common stock on The Nasdaq Global Market on the date of grant. The stock options have a 10-year term and will vest over four years, with 25% of the options vesting on the first anniversary of the vesting commencement date and the remaining 75% of the options vesting in equal monthly installments over the three years thereafter.

Vesting of the stock options is subject to the employee’s continued service to Zentalis on each vesting date.

About Zentalis Pharmaceuticals
Zentalis is a clinical oncology innovator developing a treatment approach for ovarian cancer and multiple tumor types. Leveraging therapeutics development and biomarker expertise, Zentalis is advancing monotherapy and combination studies of its investigational first-in-class WEE1 inhibitor, azenosertib. Focused on translating WEE1 science into clinical practice, we aim to equip physicians with a targeted, non-chemo, orally available medicine that enhances treatment experience, choice, and outcomes. Our mission: to unburden cancer patients with more convenience and care.​

For more information, please visit www.zentalis.com. Follow Zentalis on LinkedIn at www.linkedin.com/company/zentalis-pharmaceuticals.

ZENTALIS® and its associated logo are trademarks of Zentalis and/or its affiliates. All website addresses and other links in this press release are for information only and are not intended to be an active link or to incorporate any website or other information into this press release.

Contact: 
Aron Feingold
VP, Investor Relations & Corporate Communications
ir@zentalis.com

ANDOVER, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) — MKS Inc. (NASDAQ: MKSI), (“MKS”) a global provider of enabling technologies that transform our world, today announced the commencement of the expansion of its Atotech equipment manufacturing site in Guangzhou, China. Launched in June 2026, the expansion is now expected to be completed in the third quarter of 2027.

With the USD 25 million investment, MKS will expand the facility from 20,000 m² to 50,000 m² and plans to add 30 state-of-the-art machining and fabrication systems, create over 300 employment opportunities, and substantially increase annual sustainable production capacity.

The expansion addresses significant demand for plating equipment from the Guangzhou facility, driven by the rapid growth of manufacturers in Greater China and Southeast Asia, particularly Thailand and Vietnam.

The expansion will strengthen MKS’ manufacturing capabilities, project execution, and local installation teams, while also expanding engineering capabilities through training, knowledge sharing, and joint projects with MKS teams globally. MKS also plans to continue supporting R&D activities in Guangzhou, including dedicated space for testing and validating new products. In addition, the expansion reinforces MKS’ commitment to its customers and the region.

MKS' Atotech Guangzhou Equipment Facility Phase II Expansion Project Officially Breaks GroundMKS’ Atotech Guangzhou Equipment Facility Phase II Expansion Project Officially Breaks Ground

Left to right: Mr. Harris Li, Global Sales Director, EQ Electronics, MSD, MKS; Dr. James Tsai, Sr.  Business Director, Electronics Greater China, MSD, MKS; Mr. Deng Xu, Director of the Huangpu District Bureau of Industry and Information Technology; Mr. Rajesh Kallickal, VP Operations, MSD, MKS; Mr. Lin Weiqun, Level I Division Rank Official, Huangpu District; Mr. Tassilo Thuene, VP & GM Equipment Business, MSD, MKS; Mr. Luo Yunzhi, Director of the Yunpu Subdistrict Office of Huangpu District; Mr. Roger Zhao, Director, Equipment Operations, MSD, MKS; Mr. Raimund Zitlau, Head of Installation & Service Equipment¸ MSD, MKS; Mr. Chen Jianhang, Party Secretary and Chairman of Guangdong No.1 Construction Engineering Co., Ltd.

MKS` Atotech global and regional leaders joined the traditional lion dance eye-dotting ceremony, marking the Guangzhou expansion and future growth

MKS` Atotech global and regional leaders joined the traditional lion dance eye-dotting ceremony, marking the Guangzhou expansion and future growth

Left to right: Dr. James Tsai, Sr. Business Director, Electronics Greater China, MSD, MKS; Mr. Rajesh Kallickal, VP Operations, MSD, MKS; Mr. Tassilo Thuene, VP & GM Equipment Business, MSD, MKS; Mr. Roger Zhao, Director, Equipment Operations, MSD, MKS

About MKS Inc.
MKS Inc. (NASDAQ: MKSI) enables technologies that transform our world. We deliver foundational technology solutions to leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. We apply our broad science and engineering capabilities to create instruments, subsystems, systems, process control solutions and specialty chemicals technology that improve process performance, optimize productivity and enable unique innovations for many of the world’s leading technology and industrial companies. Our solutions are critical to addressing the challenges of miniaturization and complexity in advanced device manufacturing by enabling increased power, speed, feature enhancement, and optimized connectivity. Our solutions are also critical to addressing ever-increasing performance requirements across a wide array of specialty industrial applications. Additional information can be found at www.mks.com.

About the Atotech Brand

Atotech, a brand within the Materials Solutions Division of MKS, develops leading process and manufacturing technologies for advanced surface modification, electroless and electrolytic plating, and surface finishing. Applying a comprehensive systems-and-solutions approach, the Atotech portfolio includes chemistry, equipment, software, and services for innovative and high-technology applications. These solutions are used in a wide variety of end-markets, including datacenter, consumer electronics and communications infrastructure, as well as in numerous industrial and consumer applications such as automotive, heavy machinery, and household appliances. With its well-established innovative strength and industry-leading global TechCenter network, MKS delivers pioneering solutions through its Atotech brand – combined with unparalleled on-site support for customers worldwide. For more information, please visit us at atotech.com.

Safe Harbor for Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 regarding MKS’ manufacturing and operations expansion plans, including certain features and benefits of the expansion and the expected time of completion of the expansion. Any statements that are not statements of historical fact should be considered to be forward-looking statements. Actual events or results may differ materially from those in the forward-looking statements set forth herein, including as a result of the factors described in MKS’ Annual Report on Form 10-K for the year ended December 31, 2025 and any subsequent Quarterly Reports on Form 10-Q, as filed with the U.S. Securities and Exchange Commission. MKS is under no obligation to, and expressly disclaims any obligation to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise after the date of this press release.

Contacts:
Bill Casey
Vice President, Marketing
Telephone: +1 (630) 995-6384
Email: press@mksinst.com

Kelly Kerry, Partner
Kekst CNC
Email: kerry.kelly@kekstcnc.com

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/7fb27d13-84c8-4e24-927d-89ece8d3a38f

https://www.globenewswire.com/NewsRoom/AttachmentNg/5bc3f473-e3a6-4575-a4ff-ecd3b9537562

NEW YORK and WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced that it granted equity awards on November 2, 2026, to three newly-hired, non-executive employees. The inducement grants were approved by the Company’s independent Compensation Committee and were made as material inducements to acceptance of employment with Dianthus in accordance with Nasdaq Listing Rule 5635(c)(4).

The inducement grants consist of non-qualified stock options to purchase an aggregate of 26,000 shares of the Company’s common stock with a 10-year term and an exercise price of $82.25 per share. The options vest as to 25% on the first anniversary of the vesting commencement date and in equal monthly installments for the following 36 months. The inducement grants are subject to the terms and conditions of the Dianthus Therapeutics, Inc. Equity Inducement Plan, and the terms and conditions of a stock option agreement.

About Dianthus Therapeutics
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who aim to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases.

To learn more, please visit www.dianthustx.com and follow us on LinkedIn. 

Contact
Jennifer Davis Ruff
Dianthus Therapeutics
jdavisruff@dianthustx.com

VANCOUVER, British Columbia, Nov. 02, 2026 (GLOBE NEWSWIRE) — Pulse Oil Corp. (“Pulse” or the “Corporation”) (TSXV: PUL) announces that it intends to complete a consolidation (the “Consolidation”) of its issued and outstanding common shares (the “Common Shares”) on the basis of one (1) post-Consolidation Common Share for every twenty (20) pre-Consolidation Common Shares.

Fractional Common Shares will not be issued in connection with the Consolidation. Any fractional interest that is equal to or greater than 0.5 will be rounded up, and any fractional interest that is less than 0.5 will be rounded down to the nearest whole number of post-Consolidation Common Shares.

The Corporation intends to undertake the Consolidation as it believes doing so may improve the liquidity and marketability of the Common Shares, which may be difficult to trade under the Corporation’s existing share structure, and thereby enhance the Corporation’s attractiveness to investors in any potential future financings involving the issuance of Common Shares.

The Consolidation is subject to approval by the shareholders of the Corporation (the “Shareholders”). Accordingly, Shareholders will be asked at the annual general and special meeting of the Shareholders to be held on November 27, 2026 at 1:00 p.m. (Vancouver time) to approve the Consolidation. The Consolidation is also subject to approval by the TSX Venture Exchange (the “TSXV”).

The name of the Corporation will not be changed in conjunction with the Consolidation.

If the Shareholders and the TSXV approve the Consolidation, the currently issued and outstanding 623,465,656 Common Shares will be consolidated into approximately 31,173,283 Common Shares, subject to the rounding of any fractional post-Consolidation Common Shares. Notwithstanding any approval of the Shareholders to the Consolidation, the board of directors of the Corporation may, without further action on the part of the Shareholders, determine not to implement the Consolidation.

The Corporation currently has no plans to undertake a financing or other capital-raising transaction in connection with, or immediately following, the Consolidation.

If approved, the Corporation will issue a further news release announcing the effective date of the Consolidation and the new CUSIP/ISIN numbers for the post-Consolidation Common Shares, if applicable.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable Canadian ‎securities legislation. All statements, other than statements of historical fact, included herein are forward-‎looking information. In this news release, such statements include but are not limited to the completion of the Consolidation. There can be no assurance that such forward-‎looking information will prove to be accurate, and actual results and future events could differ materially from ‎those anticipated in such forward-looking information.

This forward-looking information reflects ‎Pulse’s current beliefs and is based on information currently available to Pulse and on ‎assumptions Pulse believes are reasonable. These assumptions include, but are not limited to, the anticipated effect of the Consolidation on the market price of the Common Shares and receipt by the Corporation of approval of the Shareholders and the TSXV to the Consolidation.

Forward-looking information is ‎subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of ‎activity, performance or achievements of Pulse to be materially different from those expressed or ‎implied by such forward-looking information. Such risks and other factors may include, but are not limited to: Shareholder and TSXV approval of the Consolidation may not be obtained; the Consolidation may not be completed on the terms currently contemplated or at all; general ‎business, commodity prices, economic, competitive, political and social uncertainties; general capital market conditions and market prices ‎for securities; changes in legislation, including environmental legislation, affecting Pulse; the timing and availability of ‎external financing on acceptable terms; and loss of key individuals‎.

A description of ‎additional risk factors that may cause actual results to differ materially from forward-looking information can ‎be found in Pulse’s disclosure documents on its profile on the System for Electronic Document Analysis and Retrieval + (SEDAR+) at www.sedarplus.ca. Although ‎Pulse has attempted to identify important factors that could cause actual results to differ materially ‎from those contained in forward-looking information, there may be other factors that cause results not to be as ‎anticipated, estimated or intended. Readers are cautioned that the foregoing list of factors is not exhaustive. ‎Readers are further cautioned not to place undue reliance on forward-looking information as there can be no ‎assurance that the plans, intentions or expectations upon which they are placed will occur. Forward-looking ‎information contained in this news release is expressly qualified by this cautionary statement. The forward-‎looking information contained in this news release represents the expectations of Pulse as of the date ‎of this news release and, accordingly, is subject to change after such date. However, Pulse expressly ‎disclaims any intention or obligation to update or revise any forward-looking information, whether as a result ‎of new information, future events or otherwise, except as expressly required by applicable securities law.‎

About Pulse

Pulse is a Canadian company incorporated under the Business Corporations Act (Alberta) that is primarily focused on a 100% working interest in the EOR Project located in West Central Alberta, Canada. The project includes two established Nisku pinnacle reef reservoirs that have been producing sweet light crude oil for over 40 years.

The Corporation has instituted a proven recovery methodology (NGL solvent injection) to further enhance the ultimate oil recovery from these two proven pools. With under 10 million barrels of oil recovered to date, and representing approximately 30% recovery factor from the pools, Pulse is moving forward to execute the EOR Project and unlock significant value for shareholders. Pulse’s total asset retirement obligations are just $2.9 million which, when compared to many peers in the industry in Western Canada, are very low.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact:

Pulse Oil Corp.

Garth Johnson
CEO
‎604-306-4421‎
garth@pulseoilcorp.com

CANTON, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) — Destination XL Group, Inc. (NASDAQ: DXLG) (the “Company”), the leading integrated-commerce specialty retailer of Big + Tall men’s clothing and footwear, announced today that its 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) will be held on Thursday, December 17, 2026. The meeting will be held at the Company’s corporate headquarters located at 555 Turnpike Street, Canton, Massachusetts 02021. The formal portion of the 2026 Annual Meeting will commence at 11:30 a.m. Eastern Time and will be held in person only, with no remote participation or streaming.

The record date for determining stockholders entitled to notice of, and to vote at, the 2026 Annual Meeting is the close of business on November 13, 2026.

Because the date of the 2026 Annual Meeting is more than 30 days after the anniversary of the Company’s 2025 Annual Meeting of Stockholders, the deadlines for stockholder proposals and director nominations set forth in the Company’s definitive proxy statement for its 2025 Annual Meeting of Stockholders, filed with the U.S. Securities and Exchange Commission (the “SEC”) on June 30, 2025, no longer apply. The Company has set the following new deadlines for the 2026 Annual Meeting:

Any stockholder proposal submitted for inclusion in the Company’s proxy materials for the 2026 Annual Meeting pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), must be received by the Corporate Secretary at the Company’s principal executive offices at 555 Turnpike Street, Canton, Massachusetts 02021 no later than the close of business on November 12, 2026, which the Company has determined is a reasonable time before it begins to print and send its proxy materials. Any such proposal must also comply with the requirements of Rule 14a-8.

Under the Company’s Fourth Amended and Restated By-Laws (the “By-Laws”), any stockholder who intends to bring business before the 2026 Annual Meeting outside of Rule 14a-8, or to nominate a person for election as a director, must deliver written notice to the Corporate Secretary at the address above no later than the close of business on November 12, 2026, which is the 10th day following the date of this press release. Any such notice must comply with the requirements of the By-Laws. Stockholders who intend to solicit proxies in support of director nominees other than the Company’s nominees must also provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than the close of business on November 12, 2026.

Additional information regarding the 2026 Annual Meeting and the matters to be considered by stockholders will be included in the Company’s definitive proxy statement when filed with the SEC.

About Destination XL Group, Inc.

Destination XL Group, Inc. is the leading retailer of Men’s Big + Tall apparel that provides the Big + Tall man the freedom to choose his own style. Subsidiaries of Destination XL Group, Inc. operate DXL Big + Tall retail and outlet stores and Casual Male XL retail and outlet stores throughout the United States, and an e-commerce website, DXL.COM, and mobile app, which offer a multi-channel solution similar to the DXL store experience with the most extensive selection of online products available anywhere for Big + Tall men. The Company is headquartered in Canton, Massachusetts, and its common stock is listed on the Nasdaq Capital Market under the symbol “DXLG.” For more information, please visit the Company’s investor relations website: https://investor.dxl.com.

Investor Relations Contact:

investor.relations@dxlg.com 
(603) 933-0541

VANCOUVER, British Columbia, Nov. 02, 2026 (GLOBE NEWSWIRE) — Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) is pleased to provide an update on its progress at the Diamba Sud gold project, Senegal.

Jorge A. Ganoza, CEO and Director of Fortuna, commented, “Following our July final investment decision on the 30% plant expansion at our flagship Séguéla mine, and with Diamba Sud advancing through the final stages of permitting, we are progressing along a clear growth path. Together, these projects underpin our target of approximately 60% growth in annual gold production to an annualized rate of 500,000 ounces from mid-2028.”

Permits

Fortuna is pleased to report that it received the Notice of Admissibility for its Diamba Sud Exploitation Permit application from Senegal’s Ministry of Mines and Geology on November 2, 2026, following initiation of the application process in February 2026. The notice confirms that the Ministry has completed the review of the application documentation, and the file complies with all regulatory requirements, marking an important final step toward the granting of the Exploitation Permit. The Company and the Ministry have worked constructively to advance the application to this stage. With this milestone completed, the Company now expects the Government´s internal approval process for the final Exploitation Permit to be completed during the fourth quarter of 2026.

The project has already received the environmental decree from Senegal’s Ministry of Environment and Ecological Transition approving its Environmental and Social Impact Assessment, as announced on June 15, 2026. Fortuna is advancing early works and committing capital to protect the project schedule and its target of first gold in mid-2028. The Company anticipates making a formal final investment decision (“FID”) upon receipt of the Exploitation Permit.

Mining Convention

Fortuna is at an advanced stage of negotiations with the State of Senegal on a new Mining Convention for the Diamba Sud project based on Senegal’s 2016 Mining Code, together with additional provisions intended to establish a fiscal stability framework for a ten-year period. The Convention remains subject to finalization and the required Government approvals.

Construction Planning and Early Works Advancing

Full-scale construction of the mine remains subject to receipt of the Exploitation Permit, Board approval of the FID and some local level customary construction approvals. The results of the positive feasibility study (“FS”) announced on June 29, 2026 demonstrated the project’s technical and economic viability (refer to Fortuna news release dated June 29, 2026, “Fortuna delivers robust Feasibility Study for the Diamba Sud Gold Project in Senegal: After-tax IRR of 60% and NPV5% of US$1 billion using US$3,500/oz”).

Early works completed or underway to support the project schedule include:

  • Assembly of the owner’s construction team, with a core of professionals largely drawn from the team that successfully delivered Fortuna´s flagship Séguéla mine in Cote d’Ivoire
  • Selection of SENET, a leading African project management and engineering company, as the project’s engineering, procurement and construction management contractor, and award of a limited order to proceed to advance early works
  • Completion of front-end engineering and design
  • 15% progress on detailed engineering for the processing plant
  • Purchase orders placed and down payments for critical long-lead equipment, including the semi-autogenous grinding (“SAG”) mill, primary crusher, and carbon-in-leach tank plate work
  • Manufacturing of the power station’s heavy fuel oil (“HFO”) and light fuel oil (“LFO”) generators with the LFO generators passing factory acceptance testing and shipped
  • Tendering and award of key construction packages, including, bulk earthworks for process plant, water storage facility, tailings storage facility, power station, and fuel storage facilities
  • New accommodation camp earthworks 80% complete, civil works 40% complete and buried services nearing completion
  • Land compensation and clearing for major infrastructure footprints

Subject to receiving the Exploitation Permit and approval of the FID in 2026, the planned key project milestones are summarized below:

Timing Milestone
Q4 2026 FID, commencement of critical-path construction activities, including earthworks for the process plant and power station, and placement of all long-lead equipment orders
Q1 2027 Completion of the 329-person accommodation camp and delivery of the LFO generators
Q2 2027 Award of the mining contract, completion of the water storage dam and water harvest dam, and first concrete placed for the process plant
Q3 2027 Mobilization and site establishment of the mining contractor and arrival of the HFO generators
Q4 2027 Commencement of pre-production mining and arrival and installation of the SAG mill
Q1 2028 Commissioning of the power station, availability of power for process plant commissioning and start-up, and completion of the TSF
Q2/Q3 2028 Process plant commissioning, first gold pour and ramp-up to nameplate plant throughput


Qualified
Person

Eric Chapman, Senior Vice President of Technical Services for Fortuna Mining Corp., is a Professional Geoscientist registered with Engineers and Geoscientists British Columbia (Registration No. 36328), and a Qualified Person as defined by National Instrument 43-101- Standards of Disclosure for Mineral Projects. Mr. Chapman has reviewed and approved the scientific and technical information contained in this news release and has verified the underlying data.

About Fortuna Mining Corp.

Fortuna Mining Corp. is a Canadian precious metals mining company with three operating mines in Argentina, Côte d’Ivoire, and Peru, and the feasibility -stage Diamba Sud Gold Project in Senegal. Our exploration portfolio spans our operating jurisdictions as well as Guinea and Guyana. Sustainability is at the core of our operations and stakeholder relationships. We produce gold and silver while creating long-term shared value through efficient production, environmental stewardship, and social responsibility. For more information, please visit our website at www.fortunamining.com

ON BEHALF OF THE BOARD

Jorge A. Ganoza
CEO and Director
Fortuna Mining Corp.

Investor Relations:

Carlos Baca | info@fmcmail.com | fortunamining.com | X | LinkedIn | YouTube | Instagram | TikTok

Cautionary Note Regarding Forward-Looking Statements

This news release contains forward-looking statements which constitute “forward-looking information” within the meaning of applicable Canadian securities legislation and “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 (collectively, “Forward-looking Statements”). All statements included herein, other than statements of historical fact, are Forward-looking Statements and are subject to a variety of known and unknown risks and uncertainties which could cause actual events or results to differ materially from those reflected in the Forward-looking Statements. Forward-looking Statements contained in this news release include, without limitation, statements with respect to: the Company’s target of approximately 500,000 GEO of annualized production from mid- 2028 and the contribution of Diamba Sud and the Séguéla plant expansion to that target; the projected economics of the Diamba Sud Project, including the net present value (NPV) of the Project and the internal rate of return (IRR) on the Project; the plans for completing the early works program; the project development timeline to production, including first gold pour in mid-2028; completion of the Ministry’s internal approval process for the Exploitation Permit and the completion of the negotiation and finalization of the Mining Convention both expected during the fourth quarter of 2026; a formal FID in the fourth quarter of 2026 upon receipt of the Exploitation Permit, subject to Board approval and receipt of other required authorizations; the estimated timing of the development, construction, commissioning and production at the Project; the timing of and future prospects for exploration and any expansion of the Project.

These statements are based on information currently available to the Company, and the Company provides no assurance that actual results will meet management’s expectations. In certain cases, Forward-looking Statements may be identified by such terms as “anticipates”, “believes”, “could”, “estimates”, “expects”, “may”, “shall”, “will”, or “would”. Forward-looking Statements contained in this news release are based on certain factors and assumptions regarding, among other things, the FS, the estimation of Mineral Resources and Mineral Reserves and any potential upgrades thereof, gold metal prices, the timing and amount of future exploration and development expenditures, the estimation of initial and sustaining capital requirements, the estimation of labor and operating costs, the availability of necessary financing and materials to continue to explore and develop the Company’s properties in the short and long-term, the progress of exploration and development activities, and the receipt of necessary regulatory approvals, the timing of the approval of the Exploitation Permit and the finalization of the Mining Convention. Other assumptions relate to currency fluctuations, environmental risks, title disputes or claims, and similar matters. While the Company considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect.

Although the Company believes the expectations expressed in such Forward-looking Statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the Forward-looking Statements. Factors that could cause actual results to differ materially from those in Forward-looking Statements include: changes in market conditions, unsuccessful exploration results, possibility of project cost overruns or unanticipated costs and expenses, changes in the costs and timing of the development of new deposits, inaccurate Mineral Resources and Mineral Reserves estimates, changes in the price of gold, unanticipated changes in key management personnel and general economic conditions; the duration and impacts of geo-political uncertainties on the Company’s production, workforce, business, operations and financial condition; the expected trends in mineral prices, inflation and currency exchange rates; that all required approvals and permits will be obtained for the Company’s business and operations on acceptable terms; that there will be no significant disruptions affecting the Company’s operations; delays in obtaining the Exploitation Permit or Cabinet approval of the finalized Mining Convention; and changes to the negotiated fiscal terms during the approval process. Mining exploration and development is an inherently risky business. Accordingly, actual events may differ materially from those projected in the Forward-looking Statements. This list is not exhaustive of the factors that may affect any of the Company’s Forward-looking Statements, including the factors included in the Company’s annual information form for the year ended December 31, 2025. These and other factors should be considered carefully, and readers should not place undue reliance on the Company’s Forward-looking Statements. Forward-looking Statements are made as of the date hereof, and the Company disclaims any obligation to update any Forward-looking Statements, whether as a result of new information, future events, or results or otherwise, except as required by law. There can be no assurance that these Forward-looking Statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.

Cautionary Note to United States Investors Concerning Mineral Resources and Mineral Reserves

Technical disclosure regarding the Company’s properties included herein has been prepared in accordance with National Instrument 43-101, Standards of Disclosure for Mineral Projects (“NI 43-101”) and the Canadian Institute of Mining, Metallurgy, and Petroleum Definition Standards on Mineral Resources and Mineral Reserves. Canadian standards, including NI 43-101, differ from the requirements of the Securities and Exchange Commission, and information included herein may not be comparable to similar information disclosed by U.S. companies.

A PDF accompanying this announcement is available at http://ml.globenewswire.com/Resource/Download/ff4c2d14-a552-4721-b9ea-3fe72638fba4

DRS will provide critical power and thermal management subsystems for a mobile counter-unmanned aircraft system capability

ARLINGTON, Va., Nov. 02, 2026 (GLOBE NEWSWIRE) — Leonardo DRS, Inc. (Nasdaq: DRS) announced today that AeroVironment, Inc. (“AV”) (Nasdaq: AVAV) has selected the company to provide rugged integration expertise for the U.S. Army’s Enduring-High Energy Laser (E-HEL) production program. DRS will apply its expertise in power management, environmental control to enable the mobile high-energy laser system intended to counter unmanned aircraft system (UAS) threats.

In September 2026, the U.S. Army announced its award to AV for the E-HEL program, describing it as the service’s first production contract for a high-energy laser weapon system. The Army said E-HEL is intended to give soldiers a scalable, affordable directed-energy system that strengthens C-UAS operations.

DRS’ subcontract supports AV’s production of LOCUST X3 laser weapon systems under the Army’s E-HEL program. AV’s 30-kilowatt, platform-agnostic LOCUST X3 is designed for integration across a range of military platforms, including the Army’s Joint Light Tactical Vehicle, with palletized configuration options also available.

“The Army’s move to production reflects the growing importance of scalable, fieldable directed-energy capabilities in countering evolving UAS threats,” said John Baylouny, president and chief executive officer of Leonardo DRS. “DRS is proud to partner with AV and bring its integration expertise to its E-HEL production effort.”

“Evolving drone threats demand systems that deliver reliable performance in demanding operational environments,” said Aaron Hankins, vice president and general manager, Leonardo DRS Land Systems. “Our team is applying experience in vehicle integration, power and thermal management to help AV deliver a mobile high-energy laser capability for the U.S. Army.”

The work builds on DRS’ previous directed-energy integration experience, including a rapid-prototyping effort in partnership with AeroVironment and other industry partners to develop a mobile counter-UAS directed-energy capability integrated into an armored vehicle. In that effort, DRS provided vehicle-integration, power, thermal-management and systems-engineering expertise for U.S. government live-fire evaluations and training in 2024 and 2025.

By applying this experience to the E-HEL program, DRS is helping bring scalable, fieldable directed-energy technology to the Army’s counter-UAS mission and broader defense-modernization efforts.

About Leonardo DRS

Leonardo DRS, Inc. (Nasdaq: DRS) is at the forefront of developing transformative defense technologies using its proven agility and delivering innovative solutions for U.S. national security customers and allies worldwide. We specialize in rapidly providing high-performance, multi-domain capabilities across next-generation advanced sensing, network computing, force protection, and electric power and propulsion. Our reputation as a trusted provider is built on a continuous focus on practical innovation, delivering quality, and meeting our customers’ most demanding mission requirements. For further information on our complete range of capabilities, visit www.LeonardoDRS.com.

Forward-Looking Statements

This communication contains statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Those statements reflect current expectations, assumptions and estimates of future performance and economic conditions. The company cautions investors that any forward-looking statements which include contract values, contract performance and our development and production of products are subject to risks and uncertainties that may cause actual results and future trends to differ materially from those matters expressed in or implied by such forward-looking statements.

Leonardo DRS Investor Relations Contact
Camilla Yanushevsky
Director, Investor Relations
+1 571 309 8216
investorrelations@drs.com

Leonardo DRS Media Contact
Charles Jones
Director, Marketing and Corporate Communications
+1 571-737-8800
charles.jones@drs.com  

Iconic Holly Performance Brands, Including NOS Nitrous Oxide Systems, Holley, Simpson and Flowmaster, Among Others Pepper the Ride’s Boarding Queue, Offering Guests an Up-Close Look at Authentic Preferred Performance Auto Parts in Recreated Props from Universal Pictures Fast & Furious Films

NASHVILLE, Tenn., Nov. 02, 2026 (GLOBE NEWSWIRE) — Holley Performance Brands (NYSE:HLLY), home to a portfolio of iconic automotive brands serving enthusiasts across the high performance aftermarket, has joined Universal Studios Hollywood as the Preferred Performance Auto Parts Partner for the theme park’s all-new high speed roller coaster, “Fast & Furious: Hollywood Drift, featuring an array of recreated film props within the ride’s boarding queue. 

This exciting collaboration with Universal Studios Hollywood extends the long-running connection with Universal Pictures’ Fast & Furious franchise, showcasing many of Holley Performance Brands as they appeared in a variety of props from the films. As guests queue up for the ride, they will have a chance to experience an up-close look at many of the high-performance brands from within Holley’s portfolio. These include NOS Nitrous Oxide Systems, Holley, Flowmaster, MSD, Hurst, AEM, B&M, Racepak, RaceQuip, Simpson, Stilo, HANS, APR and Dinan.

Fast and Furious Hollywood Drift at USH

This summer marks the 25th anniversary of the launch of one of the most iconic film franchises in cinema history. Over the course of eleven films that have stoked passion in an ever-expanding audience and have earned more than $7 billion at the worldwide box office, Universal’s record-smashing, homegrown Fast & Furious Saga has become one of the studio’s most-profitable and longest-running franchises. This year, Universal announced that a thrilling new chapter—Fast Forever—will race into theaters March 17, 2028.

Holley’s connection to the Fast & Furious franchise dates back to the early films, where NOS bottles were prominently featured as part of the films’ performance-driven storylines and other Holley brands appeared through garage signage, vehicle parts and set dressing that helped bring the films to life.

“Holley Performance Brands is deeply rooted in enthusiast culture, and few entertainment franchises have done more to celebrate and amplify that culture than Fast & Furious,” said Matthew Stevenson, President and Chief Executive Officer of Holley Performance Brands. “From the early films to this new attraction at Universal Studios Hollywood, our brands have had a meaningful connection to the performance community that helped make this franchise so iconic. We are proud to be a part of ‘Fast & Furious: Hollywood Drift’ and help bring a level of authenticity that automotive enthusiasts will recognize and appreciate.”

“Fast & Furious: Hollywood Drift” is Universal Studios Hollywood’s all-new, outdoor high-speed roller coaster that celebrates the franchise and captures the spectacle, suspense and meticulous choreography created for the films’ edge-of-your-seat driving sequences. The exhilarating new ride offers guests the chance to step into one of four ride vehicles, modeled after the cars driven by some of their favorite Fast & Furious characters, to experience the energy and thrill of the films for themselves as they soar at speeds of up to 72 MPH and a force of up to 3.6 Gs along 4,100 feet of elaborate aerial track while drifting at 360-degrees in their individual ride vehicles.

For more Holley company news, click here.

About Holley Performance Brands
Holley Performance Brands (NYSE: HLLY) is home to a portfolio of iconic brands that serve enthusiasts across the high-performance aftermarket. The company designs, engineers, manufactures and markets category-leading products and solutions for automotive enthusiasts through a focused portfolio spanning four consumer vertical groupings: American Performance, Modern Truck & Off-Road, Euro & Import, and Safety & Racing. For more than a century, Holley has built its reputation through innovation, technical expertise and a deep understanding of enthusiast culture. For more information, visit holley.com.

Media Relations Contact/s:
Nathan Espinosa/Michael Murray
Kahn Media
818-881-5246
Holley@KahnMedia.com

Investor Relations Contact/s:
Anthony Rozmus / Neel Sikka
Solebury Strategic Communications
203-428-3224
Holley@soleburystrat.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0a41e868-68ea-410f-a4bb-ad25e0c55119

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.